Approval · Notice of Compliance 22218 · 2019
CYTOMEL: Notice of Compliance 22218
Issued May 31, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22218
- Date
- May 31, 2019
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- alternate drug substance manufacturer and changes in the drug product specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYTOMEL | Not yet assigned | — |
Medicinal ingredients
- LIOTHYRONINE SODIUM 25 MCG per TAB